Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention and Treatment of Reperfusion Injury After Mechanical Thrombectomy in Acute Ischemic Stroke

NCT05282290 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT05282290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention and Treatment of Reperfusion Injury After Mechanical Thrombectomy in Acute Ischemic Stroke
Lead sponsor
Xijing Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 22, 2022
Completion date
May 1, 2024
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke patients